0
  • Notifications
  • No notifications yet

  • View All Notifications
ChemDmart
Chemxpert Database
  • About
    • About
    • Leadership
    • Advisory Board
  • Products
    • ChemProtel - Product Intelligence
    • CompFolio - One Company Profile
    • CompGroupe - Group Company Profile
    • ChemScape - Data Landscape
    • ChemDmart - E-Market Place
    • DataIntel - Data Analytics/Trends
    • DataFeed - Data News/Feed
    • CompShow- Company Showcase
  • Sources
  • Subscription
  • User Guide
  • Contact
  • Book Demo Log In
  1. Home
  2. All News
  3. Monash University Partners With Orio Therapeutics To Transform Regenerative Medicine
News Feed
course image
  • 11 Oct 2023
  • Admin
  • News Article

Monash University Partners with Orio Therapeutics to Transform Regenerative Medicine

Monash University teams up with Orio Therapeutics in hybrid equity and licencing deal to revolutionise regenerative medicine through novel drug delivery technology. The newly developed technology enhances therapeutic protein delivery by ensuring controlled, gradual release and sustained dosing directly at the injection site. This advancement enables more effective therapeutic outcomes with reduced dosage requirements.

Many protein-based therapeutics in regenerative medicine face significant challenges due to inadequate delivery systems, often necessitating large therapeutic protein doses that quickly disperse from the injection site. This situation can lead to frequent, high-dose administrations, resulting in undesirable side effects and elevated treatment costs. By maintaining precise control over delivery, this technology ensures that the therapeutic remains concentrated at the injection site, where localised action is essential for tissue regeneration and repair.

This novel technology holds the potential to revolutionise the field of regenerative medicine, offering a groundbreaking approach to tissue regeneration and repair while addressing previously unmet medical needs and enhancing patient outcomes. Moreover, the versatility of this technology allows for the enhancement of nearly any protein therapeutic that could benefit from localised delivery.

This partnership aims to bring innovative drug delivery technology into the forefront of the regenerative medicine landscape and revolutionise patient care and drive advancements in the field.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!

Categories

image
Product Related Updates
image
Certificates/Accreditation
image
Approval/Launch
image
Clinical Trial Update
image
Licensing/Partnering/Collaboration Deal
image
ODD/BTA/FTA Status
image
Merger/Acquisition
image
Warning/Recalls

Lifescience Intellipedia Pvt. Ltd.

C-89, Sector-65 Noida-U.P. 201301 (India)
Toll-Free: 18004190155
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com

USEFUL LINKS

  • Home
  • Privacy Policy
  • Terms & Conditions
  • Terms Of Use
  • Refund Policy
  • Blogs

OUR PRODUCTS

  • ChemProtel - Product Intelligence
  • CompFolio - One Company Profile
  • CompGroupe - Group Company Profile
  • ChemScape - Data Landscape
  • ChemDmart - E-Market Place
  • DataIntel - Data Analytics/Trends
  • DataFeed - Data News/Feed
  • CompShow- Company Showcase

LOCATION

© Copyright Lifescience Intellipedia Pvt. Ltd.. All Rights Reserved

Fill The Form